We then conducted tests for malaria, Legionella, influenza virus, SARS-CoV-2, HIV, herpes simplex virus, cytomegalovirus, Epstein-Barr virus IgM, Roxiella burnettii IgM (phase II antigen), R. typhi IgM, Mycoplasma pneumoniae IgM, Chlamydia IgM, respiratory syncytial virus IgM, and adenovirus IgM; results were all negative. This evidence concerns the gene CD40LG and malaria.